- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatigue in Multiple Sclerosis in New Zealand
Total 519 results
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Kessler FoundationSt. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Kessler FoundationHackensack Meridian HealthRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
Genentech, Inc.CompletedMultiple Sclerosis, Primary Progressive | Relapsing Multiple SclerorsisUnited States, Germany, Canada, Sweden
-
Kessler FoundationNational Multiple Sclerosis SocietyCompletedCognitive Impairment in Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Dominican University of New YorkRecruitingMultiple Sclerosis | Fatigue | Falls | Balance | Motor ImageryUnited States
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
Weill Medical College of Cornell UniversityGenzyme, a Sanofi CompanyCompletedSecondary Progressive Multiple SclerosisUnited States
-
NovartisCompletedClinically Isolated Syndrome | Relapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Kessler FoundationActive, not recruitingMultiple Sclerosis | Relapsing-remitting Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
LAPIX Therapeutics Inc.RecruitingMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple Sclerosis | Primary Progressive Multiple SclerosisSpain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
-
University of Missouri, Kansas CityCompletedRelapsing-remitting Multiple SclerosisUnited States
-
University of Missouri, Kansas CityNational Multiple Sclerosis SocietyCompletedRelapsing-remitting Multiple SclerosisUnited States
-
Columbia UniversityNational Multiple Sclerosis SocietyCompleted
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
Bristol-Myers SquibbTerminated
-
State University of New York at BuffaloCompletedSecondary-progressive Multiple SclerosisUnited States
-
University at BuffaloTeva Pharmaceuticals USACompleted
-
University at BuffaloWithdrawn
-
University at BuffaloCharles University, Czech Republic; General University Hospital, PragueCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
NYU Langone HealthCompleted
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Czech Republic, France, Italy, Mexico, South Africa, United Kingdom, Germany, Poland, Romania, Ukraine, Netherlands, Austria, Canada, Israel, New Zealand, Slovakia, Greece, Serbia, India, Belgium, Switzerland, ... and more
-
Washington Neuropsychology Research GroupGenzyme, a Sanofi CompanyUnknownRelapsing Remitting Multiple SclerosisUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Kessler FoundationInternational Progressive MS AllianceCompletedMemory Impairment | Cognition - Other | Multiple Sclerosis, ProgressiveUnited States
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Providence Health & ServicesGenentech, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
BiogenTerminatedMultiple Sclerosis, Relapsing-Remitting | Relapsing-Remitting Multiple SclerosisCanada
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisCanada
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more